申请人:LIGAND PHARMACEUTICALS INC.
公开号:US20150252043A1
公开(公告)日:2015-09-10
The present embodiments relate to compounds with physiological effects, such as the activation of hematopoietic growth factor receptors. The present embodiments also relate to use of the compounds to treat a variety of conditions, diseases and ailments such as hematopoietic conditions and disorders.
本实施例涉及具有生理效应的化合物,例如激活造血生长因子受体。本实施例还涉及使用这些化合物来治疗各种状况、疾病和疾患,例如造血系统疾病和疾患。